期刊文献+

^(18)F-FDG SPECT在乳腺癌术后转移诊断中的价值 被引量:1

下载PDF
导出
摘要 目的探讨18-氟代脱氧萄葡糖(18F-FDG)单光子发射计算机断层成像(SPECT)符合线路显像在乳腺癌术后转移诊断中的应用价值。方法乳腺癌术后患者97例,术后1~24个月,随访6~54个月,均行18F-FDG SPECT符合线路显像检查。按COX比例风险模型进行乳腺癌转移多因素分析,包括患者年龄、Her-2表达、转移灶部位及淋巴结转移率。结果 97例中,18F-FDG SPECT符合线路显像阳性19例,证实转移者13例;18F-FDG SPECT符合线路显像诊断灵敏度76.47%,特异度92.50%,准确性89.69%,阳性预测值68.42%,阴性预测值94.87%。淋巴结转移率是术后转移的影响因素(r=0.359 3,P<0.05)。结论18F-FDG SPECT符合线路显像可有效诊断乳腺癌术后转移。
机构地区 武汉市中心医院
出处 《山东医药》 CAS 2014年第18期64-65,共2页 Shandong Medical Journal
  • 相关文献

参考文献15

  • 1Jemal A, Siegel, Ward E, et al. Cancer statistics [ J ]. CA Cancer J Clin,2008 ,58 :71-96.
  • 2Van Dongen JA, Voogd AC, Fentiman IS, et al. Long term results of a randomized trial comparing breast-eonserving therapy with mas- tectomy: European Organization for Re-search and Treatment of Cancer[J]. J Natl Cancer lnst, 2000,92(14) :1143-1150.
  • 3韩丽君.PET/CT在乳腺癌中的临床应用[J].中国医疗器械信息,2006,12(10):10-15. 被引量:4
  • 4张春银,吴天革,刘科,陈跃,黄占文,张艳玲.^(18)F-FDG符合线路SPECT显像在乳腺癌的临床应用[J].中国医学影像技术,2006,22(6):938-940. 被引量:5
  • 5刘青竹,范义湘,吴继珍,高梅菊,李科斌.^(18)F-FDG SPECT/PET代谢显像对肺癌的诊断价值[J].肿瘤学杂志,2009,15(12):1060-1062. 被引量:6
  • 6Yap CS, Seltzer MA, Schiepers C, et al. Impact of whole-body is F-FDG PET on staging and managing patients with breast cancer: the referring physician' sperspective [ J ]. J Nucl Med, 2001,42 (9) :1334-1337.
  • 7Dirisamer A, Halpem BS, Flory D, et al. Integrated contrast-en- hanced diagnostic whole-body PET/CT as a first-line restaging mo- dality in patients with suspected metastatic re-currence of breast cancer[J]. Eur J Radiol, 2010,73(2) :294-299.
  • 8Piccart-Gebhart M J, Procter M, Leyland-Jones B, et al. Trastuzumab after adjuvant chemotherapy in Her-2-positive breast cancer[ J ]. N EngI J Med, 2005,352(16) :1659-1663.
  • 9Gago FE,Fanelli MA, Ciocca DR, et al. Co-expression of steroid hormone receptors( estrogen receptoralpha and/or progesterone re- ceptors) and Her-2-neu in breast cancer: Clinical outcome following tamoxifen-based adjuvanttherapy[ J]. J Steroid Biochem Mol Biol, 2006,98 ( 1 ) :36-39.
  • 10Pinto AE,Andre S, Pereira T, et al. C-erbB-2 oncopretein overex- pression identifiers a subgroup of estrogen receptor positive( ER + ) breast cancer patients with poor prognosis[J]. Ann Oncol, 2001, 12(4) :525-528.

二级参考文献32

共引文献29

同被引文献11

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部